ABOUT US

Andrei A. Zlota, Ph.D. is the President and Chief Chemical Engineer of The Zlota Company, LLC, a firm specializing in the design and scale-up of robust processes, and in data mining.

Dr. Zlota has over 15 years experience in the pharmaceutical and personal care industries, at Biopharm, Monsanto, Gillette and Sepracor, both in cGMP manufacturing, as well as process research, development, and scale-up. Andrei has led the design, successful and rapid scale-up of several chemical and formulation processes.

His areas of expertise include automated laboratory reactors, mixing and scale-up, statistical design of experiments, medium-, and high throughput technologies, and process analytical technologies. Andrei championed the technology transfer of several API crystallization processes to plants in the U.S., Canada, India, and Romania. He uses statistical design of experiments and risk analysis for process investigations, critical process parameter evaluation, and robust process design.

Andrei has led efforts with active pharmaceutical ingredient solid-state characterization, polymorph, and salt screening.

Dr. Zlota was a speaker at several industry conferences such as the American Institute of Chemical Engineers, the International Quality and Productivity Center, the Institute for International Research, the Mettler Process Development User Forum, etc. Andrei co-authored more than 20 articles in peer-reviewed journals, several patent applications, and a granted patent. He contributed a process scale-up chapter to a Wiley book on Drug Discovery and Development.

Dr. Zlota enjoys teaching, and he is an adjunct professor at the Massachusetts College of Pharmacy and Health Sciences, and at the Boston University Medical School.

Andrei holds a Ph.D. in chemistry, and an M.S. in Chemical Engineering.

Dr. Zlota is a member of the American Institute of Chemical Engineers and of the American Chemical Society.